Sandra L. Kweder MD

Sandra L. Kweder, M.D., is Deputy Director of the Europe Office in FDA’s Office of Global Policy and Strategy (OGPS). Before joining OGPS, Dr. Kweder was Deputy Director, Office of New Drugs in FDA’s Center for Drug Evaluation & Research (CDER). In CDER, she actively led several initiatives including improvements in the drug review process, modernizing nonprescription drug review, building a systematic drug shortage prevention and management program, patient-focused drug development and clinical outcomes assessment, and the growth and development of pediatrics and maternal health as standard aspects of drug development.

Dr. Kweder was commissioned in the U.S. Public Health Service upon entering the Uniformed Services University of Health Sciences (USUHS) (retiring in 2013 at the rank of Rear Admiral). Following internal medicine training at Walter Reed Army Medical Center, she joined the FDA in the Division of Antiviral Drugs to address the growing field of HIV drug development. She has since held many positions with the FDA in premarket and postmarket regulation. Dr. Kweder was active in medical education as an adjunct faculty member of USUHS, training residents and medical students in Internal Medicine and utilizing her fellowship training from Brown University in Obstetric and Consultative Medicine.